Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 617159
                    [Title] => New agents for gout provide alternatives to allopurinol
                    [Summary] => 
The likely approval of febuxostat for the treatment of gout means that there soon will be an alternative for the underserved group of patients with severe disease who cannot tolerate allopurinol.
                    [DatePublished] => 2010-10-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

URICASE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 617159
                    [Title] => New agents for gout provide alternatives to allopurinol
                    [Summary] => 
The likely approval of febuxostat for the treatment of gout means that there soon will be an alternative for the underserved group of patients with severe disease who cannot tolerate allopurinol.
                    [DatePublished] => 2010-10-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

New agents for gout provide alternatives to allopurinol

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | October 3, 2010 - 12:00am

The likely approval of febuxostat for the treatment of gout means that there soon will be an alternative for the underserved group of patients with severe disease who cannot tolerate allopurinol.

Opinion